|
Average age (years)
|
n = 121
|
SD
|
| |
59.6
|
11.1
|
|
Country of Birth
|
n = 121
|
%
|
|
Australia (2 ATSIa)
|
92
|
76.0
|
|
New Zealand (2 Maori, 2 Samoan)
|
6
|
5.0
|
|
Europe / United Kingdom
|
17
|
14.0
|
|
Africa
|
3
|
2.5
|
|
Asia
|
3
|
2.5
|
|
Languages spoken at home
|
n = 120
|
%
|
|
English
|
116
|
96.7
|
|
English and another language
|
4
|
3.3
|
|
Median years since diagnosis
|
n = 121
|
range
|
| |
3.6
|
0.3–36.5
|
|
Diagnosis
|
n = 121
|
%
|
|
Breast or gynaecological cancer
|
82
|
67.8
|
|
Haematological, bowel, skin or lung cancer
|
25
|
20.7
|
|
Prostate cancer
|
4
|
3.3
|
|
Other (includes multiple primary cancers)
|
10
|
8.3
|
|
Current treatment
|
n = 121
|
%
|
|
No treatment
|
65
|
53.7
|
|
Long-term treatment / rehabilitation
|
46
|
38.0
|
|
Active treatment
|
10
|
8.3
|
|
Treatment in last 12 monthsb
|
n = 120
|
%
|
|
None
|
50
|
41.6
|
|
Surgery
|
38
|
31.6
|
|
Radiotherapy
|
31
|
25.8
|
|
Chemotherapy
|
26
|
21.6
|
|
Other cancer medication
|
25
|
20.8
|
